Mitsubishi UFJ Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206M Buy
532,437
+28,812
+6% +$10.7M 0.11% 149
2026
Q1
$147M Buy
503,625
+33,239
+7% +$10.9M 0.1% 189
2025
Q4
$167M Buy
470,386
+15,375
+3% +$5.2M 0.11% 151
2025
Q3
$147M Buy
455,011
+21,124
+5% +$6.57M 0.11% 163
2025
Q2
$169M Buy
433,887
+19,539
+5% +$7.86M 0.13% 138
2025
Q1
$180M Buy
414,348
+52,317
+14% +$21M 0.17% 122
2024
Q4
$135M Buy
362,031
+21,550
+6% +$9.02M 0.13% 138
2024
Q3
$177M Buy
340,481
+28,696
+9% +$15.3M 0.19% 102
2024
Q2
$169M Buy
311,785
+31,230
+11% +$16.5M 0.21% 95
2024
Q1
$145M Buy
280,555
+48,195
+21% +$24M 0.2% 97
2023
Q4
$112M Buy
232,360
+14,310
+7% +$6.62M 0.2% 100
2023
Q3
$94.9M Buy
218,050
+17,278
+9% +$7.84M 0.19% 101
2023
Q2
$89.2M Buy
200,772
+12,418
+7% +$5.73M 0.19% 105
2023
Q1
$86.6M Buy
188,354
+18,623
+11% +$8.86M 0.21% 101
2022
Q4
$85.2M Buy
169,731
+19,341
+13% +$9.82M 0.23% 94
2022
Q3
$68.3M Buy
150,390
+14,113
+10% +$6.75M 0.22% 88
2022
Q2
$65.8M Buy
136,277
+9,712
+8% +$4.8M 0.29% 74
2022
Q1
$62.2M Buy
126,565
+10,776
+9% +$4.93M 0.25% 84
2021
Q4
$53.8M Buy
115,789
+15,206
+15% +$6.4M 0.21% 96
2021
Q3
$37.5M Buy
100,583
+9,434
+10% +$3.59M 0.18% 110
2021
Q2
$34.8M Buy
91,149
+10,218
+13% +$3.9M 0.19% 105
2021
Q1
$29.1M Buy
80,931
+8,642
+12% +$2.78M 0.19% 112
2020
Q4
$23.2M Buy
72,289
+3,628
+5% +$1.11M 0.18% 117
2020
Q3
$18.4M Buy
68,661
+10,498
+18% +$2.82M 0.17% 123
2020
Q2
$15.3M Buy
58,163
+6,699
+13% +$1.79M 0.17% 123
2020
Q1
$11.7M Buy
51,464
+405
+0.8% +$110K 0.18% 121
2019
Q4
$15.2M Buy
51,059
+6,065
+13% +$1.67M 0.2% 103
2019
Q3
$10.8M Buy
44,994
+1,823
+4% +$499K 0.18% 118
2019
Q2
$12.2M Buy
43,171
+8,312
+24% +$2.27M 0.21% 94
2019
Q1
$10M Buy
34,859
+2,052
+6% +$593K 0.21% 103
2018
Q4
$8.15M Sell
32,807
-1,537
-4% -$423K 0.21% 106
2018
Q3
$9.41M Sell
34,344
-574
-2% -$149K 0.19% 104
2018
Q2
$8.31M Sell
34,918
-561
-2% -$130K 0.18% 117
2018
Q1
$7.79M Sell
35,479
-4,453
-11% -$1.05M 0.18% 122
2017
Q4
$9.15M Buy
39,932
+355
+0.9% +$75.6K 0.2% 110
2017
Q3
$7.51M Buy
39,577
+1,566
+4% +$298K 0.18% 125
2017
Q2
$7.15M Sell
38,011
-4,311
-10% -$775K 0.18% 128
2017
Q1
$7M Buy
42,322
+1,587
+4% +$252K 0.16% 132
2016
Q4
$5.83M Buy
40,735
+211
+0.5% +$28.3K 0.14% 152
2016
Q3
$5.08M Buy
40,524
+1,437
+4% +$186K 0.13% 168
2016
Q2
$5.13M Buy
39,087
+1,157
+3% +$158K 0.13% 152
2016
Q1
$5.27M Buy
37,930
+3,227
+9% +$431K 0.14% 138
2015
Q4
$4.84M Buy
34,703
+993
+3% +$137K 0.14% 143
2015
Q3
$4.72M Sell
33,710
-479
-1% -$72K 0.15% 138
2015
Q2
$5.61M Sell
34,189
-3,592
-10% -$574K 0.17% 117
2015
Q1
$5.83M Sell
37,781
-2,758
-7% -$393K 0.17% 122
2014
Q4
$5.09M Sell
40,539
-6,185
-13% -$764K 0.16% 141
2014
Q3
$5.59M Sell
46,724
-20,672
-31% -$2.37M 0.17% 130
2014
Q2
$7.25M Sell
67,396
-4,831
-7% -$498K 0.19% 125
2014
Q1
$7.19M Buy
72,227
+681
+1% +$61.6K 0.19% 118
2013
Q4
$6.48M Sell
71,546
-15,966
-18% -$1.42M 0.19% 123
2013
Q3
$7.32M Buy
87,512
+3,407
+4% +$292K 0.19% 122
2013
Q2
$6.88M Buy
+84,105
New +$6.29M 0.2% 115

Other funds holding ELV

Mitsubishi UFJ Asset Management's ELV Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Elevance Health (ELV) stake by 5.7% in Q2 2026, buying an estimated $10.7M and bringing the position to 532,437 shares worth $206M. The position accounts for 0.11% of the portfolio, ranked #149.

Mitsubishi UFJ Asset Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 532,437 shares of Elevance Health worth $206M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 28,812 Elevance Health shares in Q2 2026, an estimated $10.7M.
  • Elevance Health made up 0.11% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #149 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.